Navigation Links
Commentary and podcast on landmark gene therapy clinical trial for hemophilia B
Date:12/13/2011

se included a self-complementary genome to increase efficiency pioneered by R. Jude Samulski, PhD, Director, Gene Therapy Center, University of North Carolina at Chapel Hill, and the use of a novel AAV capsid from a natural rhesus monkey isolate called AAV8, which was discovered and developed by James M. Wilson, MD, PhD, Editor-in-Chief of Human Gene Therapy and Human Gene Therapy Methods, and Director of the Gene Therapy Program, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.

Recently published articles in Human Gene Therapy document the development and optimization of the AAV vectors used to deliver the FIX gene in this clinical trial. Two key papers are:

"The successful treatment of patients with hemophilia B with gene therapy is a landmark event representing the culmination of over 20 years of work by many laboratories," says James M. Wilson, MD, PhD. "We are delighted that Human Gene Therapy was a venue for publishing critical aspects of the development of this product."


'/>"/>

Contact: Cathia Falvey
cfalvey@liebertpub.com
914-740-2165
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert  

Page: 1 2

Related biology news :

1. BUSM faculty author commentary on the global challenges of emerging viral infections
2. Expert commentary on Earth Days 40th anniversary
3. SectorWatch.biz Issues Commentary for Investors of Homeland Defense Companies FOUR, MAGS, NSSC, PNTR, BCO, and CKP
4. New American Chemical Society podcast: Genetically-engineered spider silk for gene therapy
5. American Migraine Foundation launches new podcast series
6. New American Chemical Society podcast: Tiny sea creature and a new medical adhesive
7. LSUHSC conducts landmark study of mid, long-term health effects of oil exposure
8. Landmark report reveals immense burden of osteoporotic fractures in Europe
9. OHSU Doernbecher Childrens Hospital conducts second phase of landmark Batten study
10. Terumo Medical Corp. reports first US implant in landmark study enrolling in US and Japan
11. Fruit flies use horizontal landmarks for altitude control, says Caltech research team
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Commentary and podcast on landmark gene therapy clinical trial for hemophilia B
(Date:7/11/2014)... Tenn., July 11, 2014--Researchers at the Department of ... R&D 100 awards, presented by R&D Magazine in ... , "These awards recognize the tremendous value of ... Moniz. "Research and development at the National Labs ... challenges and pursue the scientific and technological innovations ...
(Date:7/11/2014)... . X-ray ... of X-rays through a specimen instead of attenuation resulting ... often of much higher quality than those based on ... Pfeiffer are particularly interested in developing new approaches for ... imaging. One main goal is to make this method ...
(Date:7/11/2014)... Social animals often develop relationships with other group members ... In wild chacma baboons the strategy for grooming activities ... are just published in the scientific journal Biology ... of baboons is not practiced without ulterior motives. To ... for the individual, while grooming another individual can provide ...
Breaking Biology News(10 mins):ORNL wins eight R&D 100s 2ORNL wins eight R&D 100s 3ORNL wins eight R&D 100s 4New simple setup for X-ray phase contrast 2Baboons groom early in the day to get benefits later 2
... in German . There are many ... But how can the chemical properties of a material be ... of Technology developed a method to attach molecules at exactly ... can allow the positioning of chemical signals, telling living cells ...
... benefits of breast milk have long been appreciated, but ... a unique property that makes mother,s milk better than ... The finding, published in the August issue of ... explains how breast milk, but not infant formula, fosters ...
... it out to regulate gene expression on the DNA ... enzymes that transcribe DNA into RNA. Their repressor opponents ... coil around histone proteins, an amalgam called chromatin, effectively ... RNA strand. Both teams maneuver by chemically modifying ...
Cached Biology News:The laser beam as a '3-D painter' 2Breast milk promotes a different gut flora growth than infant formulas 2Breast milk promotes a different gut flora growth than infant formulas 3Controlling gene expression: How chromatin remodelers block a histone pass 2Controlling gene expression: How chromatin remodelers block a histone pass 3
(Date:7/11/2014)... 11, 2014 , Not for release, ... or from any jurisdiction where to do so would constitute ... Shire plc ("Shire" or the "Company") (LSE: SHP, NASDAQ: ...  Shire confirms it has held a meeting with representatives of ... without the prior agreement or approval of AbbVie. ...
(Date:7/11/2014)... 2014 /CNW/ - Sunovion Pharmaceuticals Canada Inc. (Sunovion) today ... acetate) for use as a once-daily adjunctive therapy for ... who are not satisfactorily controlled with conventional therapy.  APTIOM ... under 18 years of age. Epilepsy ... according to Epilepsy Canada, it affects 0.6% of the ...
(Date:7/10/2014)... 2014 Product and process impurities ... abundance and are often “lost in the noise,” ... Join presenters Dr. Rowel Tobias, Senior Scientist, Protein ... Head of Quality at Nanotherapeutics, Inc., to lear ... speed detection and quantitation while achieving the required ...
(Date:7/10/2014)... CA (PRWEB) July 10, 2014 Unraveling ... closer together. The Archer Family purchased a ... within DNA, but ended up with a lifetime of ... contained within the family members’ DNA genuinely brought the ... decided to search deeper into genetic history and prior ...
Breaking Biology Technology:Shire plc - Statement re: Media Speculation 2Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 2Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 3Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 4Novel Ms Techniques Speed Detection of Biopharmaceutical Product and Process Impurities, New Webinar Hosted by Xtalks 2Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 2Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 3Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 4Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 5
... Fusion Platform Includes Innovative Biometric ... ... 12 WCC Smart Search & Match,a leading provider of ... Systems, a leader in providing,innovative eye biometric technology for identification ...
... Throughout a ... Product,s Lifecycle, NEW YORK, Feb. ... an industry leader in patient,enrollment for clinical trials, will join the ... this partnership, Ketchum,will greatly expand the depth of services offered to ...
... (NYSE: BMY ) today announced that the company,s ... the Board. Mr. Cornelius, who,was named chief executive officer ... well. Mr. Cornelius, current employment contract, which,expires in May ... B.,Campbell, chairman, president and CEO, Textron Inc., as lead ...
Cached Biology Technology:WCC Smart Search & Match and Retica Announce Global Collaboration 2Ketchum Joins Forces with Clinical Trial Recruitment Agency MMG 2Ketchum Joins Forces with Clinical Trial Recruitment Agency MMG 3Ketchum Joins Forces with Clinical Trial Recruitment Agency MMG 4Bristol-Myers Squibb Board Elects James M. Cornelius Chairman of the Board 2